Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation

• Prif Awduron: Elodie Cheyssac (Awdur), Hamidou Savadogo (Awdur), Nathan Lagoutte (Awdur), Véronique Baudouin (Awdur), Marina Charbit (Awdur), Robert Novo (Awdur), Anne-Laure S (Awdur), Marc Fila (Awdur), Stéphane Decramer (Awdur), Elodie Merieau (Awdur), Ariane Zaloszyc (Awdur), Jérôme Harambat (Awdur), Gwenaelle Roussey (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

IntroductionPrimary infection or reactivation of Epstein-Barr Virus (EBV) is a significant cause of morbidity and mortality in pediatric kidney transplantation. Valganciclovir (VGC) treatment is recommended for prophylaxis of cytomegalovirus infection, but its role for the prevention of EBV infectio...